Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
NCT ID: NCT04427384
Last Updated: 2026-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2020-09-11
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain Metastases
NCT04545814
A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)
NCT01821443
Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis
NCT01705548
Image Guided Therapy in the Treatment of Gliomas
NCT01263821
HF-SRT vs. HS-WBRT in Treating Patients With Brain Oligometastases
NCT05807165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GammaTile
Patients who have received permanent implants of GammaTile radiation therapy immediately following brain tumor resection.
GammaTile
Surgically Targeted Radiation Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GammaTile
Surgically Targeted Radiation Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Willing and able to provide informed consent and to participate in all evaluations.
Exclusion Criteria
2. Major medical or psychiatric illness, which, in the investigator's opinion would prevent completion of treatment, ability to complete assessments at the time of enrollment, and/or interfere with follow ups.
3. Subjects who, in the investigator's opinion, are unable to understand the protocol or to give informed consent, have a history of poor cooperation, noncompliance with medical treatment, or difficulty in returning for follow up care. A legally authorized representative may provide consent if the potential subject lacks the capacity to provide consent themselves.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GT Medical Technologies, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael A. Garcia, MD, MS
Role: STUDY_DIRECTOR
GT Medical Technologies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HonorHeath Scottsdale Osborn Medical Center
Phoenix, Arizona, United States
University of Arkansas Medical Center
Little Rock, Arkansas, United States
Eden Medical Center
Castro Valley, California, United States
UCSD Moores Cancer Center
La Jolla, California, United States
MemorialCare Health System
Laguna Hills, California, United States
Desert Regional Medical Center
Palm Springs, California, United States
California Pacific Medical Center, Sutter health
San Francisco, California, United States
Centura
Denver, Colorado, United States
Colorado Brain & Spine Institute: Swedish Campus
Englewood, Colorado, United States
BayCare Health
Clearwater, Florida, United States
Ascension St. Vincent's
Jacksonville, Florida, United States
Miami Cancer Institute, Baptist Health South Florida
Miami, Florida, United States
Advent Health Orlando
Orlando, Florida, United States
Orlando Health
Orlando, Florida, United States
Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital
Tampa, Florida, United States
Cleveland Clinic Florida- Weston
Weston, Florida, United States
Piedmont Healthcare
Atlanta, Georgia, United States
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
St. Alphonsus Regional Medical Center
Boise, Idaho, United States
Goodman Campbell Brain and Spine
Carmel, Indiana, United States
Indiana University, IU Health Methodist Hospital
Indianapolis, Indiana, United States
KUMC Dept of Neurosurgery
Kansas City, Kansas, United States
Univeristy of Louisville Health
Louisville, Kentucky, United States
Norton Cancer Institute
Louisville, Kentucky, United States
Willis-Knighton Medical Center
Shreveport, Louisiana, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Henry Ford Health System
Detroit, Michigan, United States
Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
University of Minnesota
Minneapolis, Minnesota, United States
University of Nebraska
Omaha, Nebraska, United States
Clinical Research dep. Davison Place. Englewood Health
Englewood, New Jersey, United States
Albany Medical Center
Albany, New York, United States
Mount Sinai Hospital
New York, New York, United States
SUNY Upstate Medical Center
Syracuse, New York, United States
Montefiore Einstein
The Bronx, New York, United States
Westchester Medical Center
Valhalla, New York, United States
University of North Carolina Health
Chapel Hill, North Carolina, United States
Vidant Heath - ECU Medical Center
Greenville, North Carolina, United States
Atlantic Brain & Spine
Wilmington, North Carolina, United States
Mayfield Brain and Spine
Cincinnati, Ohio, United States
Kettering Health
Kettering, Ohio, United States
St Luke's University Health, Sacred Heart Campus
Allentown, Pennsylvania, United States
Penn State Health
Hershey, Pennsylvania, United States
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Brown University Health
Providence, Rhode Island, United States
CHI Memorial Hospital, CommonSpirit
Chattanooga, Tennessee, United States
UT Southwestern Simmons Cancer Center
Dallas, Texas, United States
Baylor St. Luke's Medical Center | Baylor College of Medicine
Houston, Texas, United States
Houston Methodist Hospital
Houston, Texas, United States
University of Texas Health Science Center of San Antonio
San Antonio, Texas, United States
Texas Oncology-The Woodlands
The Woodlands, Texas, United States
INOVA Health
Fairfax, Virginia, United States
Virginia Mason
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
John Wanebo, MD
Role: primary
Analiz Rodriguez, MD, PhD
Role: primary
Lawrence Dickinson, MD
Role: primary
David Piccioni, MD, PhD
Role: primary
Amir Lavaf, MD
Role: primary
Lewis Leng, MD
Role: primary
Angela Bohnen, MD
Role: primary
Vadim Tsvankin, MD
Role: primary
Devon Haydon, MD
Role: primary
Amanda Lindewood
Role: primary
Rupesh Kotecha, MD
Role: primary
Imran Mohiuddin, MD
Role: primary
Catherine Mercado, MD
Role: primary
Tulika Ranjan, MD
Role: primary
Role: backup
Surabhi Ranjan, MD, FACP
Role: primary
Adam Nowlan, MD
Role: primary
Kimberly Bojanowski
Role: primary
Ondrej Choutka
Role: primary
Mitesh Shah
Role: primary
Kushal Shah
Role: primary
Akshitkumar Mistry, MD
Role: primary
Stephen Duggan
Role: primary
Adam M Robin, MD
Role: primary
John Trusheim, MD
Role: primary
Lindsey Sloan, MD, PhD
Role: primary
Michele Aizenberg, MD
Role: primary
Kevin Yao, MD
Role: primary
Dubin David, MD
Role: backup
Tuba Ahmed
Role: primary
Harish Babu, MD
Role: primary
Genesis Liriano
Role: primary
Simon Hanft
Role: primary
Colette Shen, MD
Role: primary
Stuart Lee, MD
Role: primary
Vincent DiNapoli, MD
Role: primary
Mark Hoeprich, MD
Role: primary
William Smith, MD
Role: primary
Rachel Horstman
Role: primary
Toral Patel, MD
Role: primary
Akash Patel, MD
Role: primary
David Baskin, MD
Role: primary
John Floyd, MD
Role: primary
Daniel Kim, MD
Role: primary
Huong Pham, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GTM-101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.